Cargando…
SARS-CoV-2 and HIV-1 — a tale of two vaccines
The rapid development of COVID-19 vaccines and their deployment in less than a year is a scientific and medical triumph that has raised a key question. Why do we have several SARS-CoV-2 vaccines but do not have a single HIV-1 vaccine?
Autor principal: | Haynes, Barton F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284417/ https://www.ncbi.nlm.nih.gov/pubmed/34272508 http://dx.doi.org/10.1038/s41577-021-00589-w |
Ejemplares similares
-
Publisher Correction: SARS-CoV-2 and HIV-1 — a tale of two vaccines
por: Haynes, Barton F.
Publicado: (2021) -
Author Correction: SARS-CoV-2 and HIV-1 – A Tale of Two Vaccines
por: Haynes, Barton F.
Publicado: (2021) -
SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021) -
Natural immunity helps overcome the age-related decline of SARS-CoV-2 vaccine immunogenicity
por: Verschoor, Chris P, et al.
Publicado: (2022) -
Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)